About MagnetOs
MagnetOs grows bone even in
soft tissue thanks to our unique
NeedleGrip
™
surface technology
which provides traction for our body's
vitally important 'pro-healing' immune
cells (M2 macrophages).
*1
This in turn,
unlocks previously untapped potential
to stimulate stem cells - and form new
bone throughout the graft.
†2-4
As a result, MagnetOs is proven to
be equivalent to the gold standard of
autograft for spinal fusions.
*3,4
Together, let's move the needle in
spinal fusion rates
If you want to know more about
MagnetOs and the growing body of
science behind it:
• Visit our web site
• Download our latest study from
Project Fusion.
•
experts.
Scan to learn more
References: 1. Duan, et al. eCM. 2019;37:60-73. 2. Van Dijk, et al. eCM. 2021;40:756-773. 3. Van Dijk, et al. JOR Spine. 2018;e1039. 4. Van Dijk, et al. J Biomed Mater Res. Part B: Appl Biomater. 2019;107(6):2080-2090.
*MagnetOs has been proven to generate more predictable fusions than two commercially available alternatives in an ovine model of posterolateral fusion. Results from in vivo laboratory testing may not be predictive of clinical
experience in humans. For important safety and intended use information please visit kurosbio.com.
†
MagnetOs is not cleared by FDA as an osteoinductive bone graft.
Manufactured by Kuros Biosciences BV,
Prof Bronkhorstlaan 10, Building 48, 3723 MB Bilthoven, The Netherlands.
KurosBio.com
MagnetOs and NeedleGrip
are trademarks of Kuros Biosciences.
PROMO/MAG/US/111-21
R01
Aug'21
